Bio-Gene Technology Limited

ASX (AUD): Bio-Gene Technology Limited (BGT)

Last Price

0.016

Today's Change

-0.001 (5.88%)

Day's Change

0.016 - 0.016

Trading Volume

384,823

Overview

Market Cap

4 Million

Shares Outstanding

266 Million

Avg Volume

200,047

Avg Price (50 Days)

0.02

Avg Price (200 Days)

0.04

PE Ratio

-1.60

EPS

-0.01

Earnings Announcement

27-Jul-2025

Previous Close

0.02

Open

0.02

Day's Range

0.016 - 0.016

Year Range

0.016 - 0.071

Trading Volume

384,823

Price Change Highlight

1 Day Change

-5.88%

5 Day Change

-15.79%

1 Month Change

-30.43%

3 Month Change

-51.52%

6 Month Change

-58.97%

Ytd Change

-62.79%

1 Year Change

-67.35%

3 Year Change

-88.57%

5 Year Change

-87.69%

10 Year Change

-92.00%

Max Change

-92.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment